Tinker Bell Express has received hundreds of millions of dollars in financing from SoftBank China Pharmaceutical O2O to usher in a new retail wind

Recently, pharmaceutical O2O company Tinker Bell Express announced that it has received hundreds of millions of yuan in financing, the investor is SoftBank China. The move comes after Tinker Bell Express received a win-win financing in December. According to the Securities Daily reporter understand that both financings belong to the scope of round A.Yang Wenlong, founder of
Tinker Bell Express, said that at present, Tinker Bell Express has been in the north to Guangshucheng and other cities to achieve online 7 x 24 hours professional pharmacists free guidance, 28 minutes offline delivery to home. This round of financing will be mainly used for the existing city pharmacy network encryption, shorten the distribution distance, ensure the quality of service, while rapidly expanding other cities, as soon as possible to complete the national layout.
It is worth mentioning that, although Ali, JD.com and other e-commerce O2O enterprises to expand the category, but the existing relevant regulations, the premise of the opening of online pharmacies is that there must be chain-operated physical stores offline, which makes Ali, JD.com and other forces have not caught, but also let "Dingding Express" and other companies with a large number of physical pharmacies see opportunities. By analogy, in April last year, the same type of company "fast prescription drug delivery" received a step-by-step pharmaceutical 60 million yuan investment.
in the industry, Tinker Bell Express can get SoftBank endorsements, but also means that the medicine O2O's mouth or will come. Public information shows that in recent years, SoftBank China is accelerating the layout of the medical and health industry, investing in Huada Gene, Dean Diagnostics, Libang Instruments, Jingxuan shares, Anhan Medical, etc., of which Dingding Express became the first pharmaceutical e-commerce platform based on "new retail" investment.
Compared to fresh, takeaway and other categories, drug purchase belongs to low-frequency consumption and policy requirements must be their own logistics, so it is difficult for enterprises to achieve profitability, the overall expansion of the industry is slow, many new enterees have to taste the end, such as U medicine U medicine, Kangkang buy medicine and so on. Data from Tinker Bell Express show that at the end of 2016, Tinker Bell Express was the first to make a profit in the Beijing market.
, the pursuit of large-scale profitability is not the most important thing at the moment. "Continually improving the product matrix and enriching the drug types, continuously improving the user experience, addressing user pain points, and thus increasing user stickiness are our most important concerns."
it is understood that up to now, Dingding Express launched the "FSC (factoryservicecustomer) pharmaceutical enterprise alliance" members have reached more than 460, including Sino-American Ske, Bayer, Guangyuyuan and a large number of well-known pharmaceutical companies.
fact, Tinker Bell Express is strengthening its internal and external linkage advantages. Yang Wenlong revealed that Tinker Bell Express will further improve the FSC alliance, enrich the drug type, build a chain of pharmacies O2O new industry, through the construction of a direct pharmacy system, integration of online and offline resources. (Securities Daily)